Skip to main content

stock

ALLR · Allarity Therapeutics, Inc.

What Allarity Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ALLR price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ALLR.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
15,910,724 as of 2026-08-14 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-348.8%
ROA
-38.4%

Health

Current ratio
1.1x
Debt/equity
—

Deep value

NCAV
$3.15M
NCAV per share
$0.20
Price/NCAV
Locked
NNWC
-$11.60M
NNWC per share
-$0.73
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$0—-$2.67M-$3.40M
10-Q filed 2026-08-14
2026-03-31$25,000—-$2.69M-$2.75M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——-$2.92M-$3.37M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——-$2.52M-$2.81M
10-Q filed 2025-11-14
2025-06-30$0—-$4.13M-$2.32M
10-Q filed 2026-08-14
2025-03-31$0—-$3.04M-$2.73M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——-$7.32M-$7.45M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——-$12.31M-$11.59M
10-Q filed 2025-11-14
Assets
$32.12M
Equity
$3.54M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$320,000-$12.61M-$11.23M-$14.83M
2024-12-31$0-$27.24M-$24.52M-$17.65M
2023-12-31—-$17.13M-$11.90M-$12.74M
2022-12-31—-$34.46M-$16.06M-$16.84M
2021-12-31—-$26.56M-$26.65M—
2020-12-31—-$8.32M-$6.62M-$7.25M

Company filings

since Fri Apr 24 · 2 offering filings in 12 months

events

  • Other event

    Other event
    Oct 18-K
  • Other event

    Other event
    Sep 298-K
  • Other event

    Other event
    Sep 168-K
  • Other event

    Other event
    Sep 148-K
  • Results

    Results
    Aug 148-K
  • Shareholder vote results, Other event

    Shareholder vote resultsOther event
    Jul 18-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ALLR, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ALLR.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ALLR.

nakagai

Signals on ALLR come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ALLR board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Allarity Therapeutics, Inc. (ALLR): SEC filings, financials and insider trades · Nakagai